Intermolecular (IMI) versus Coherent (COHR) Head-To-Head Review

Intermolecular (NASDAQ: IMI) and Coherent (NASDAQ:COHR) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Volatility and Risk

Intermolecular has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, Coherent has a beta of 0.78, meaning that its share price is 22% less volatile than the S&P 500.

Insider and Institutional Ownership

38.0% of Intermolecular shares are owned by institutional investors. Comparatively, 90.2% of Coherent shares are owned by institutional investors. 45.4% of Intermolecular shares are owned by company insiders. Comparatively, 1.4% of Coherent shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Intermolecular and Coherent’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Intermolecular $39.08 million 1.38 -$5.32 million ($0.38) -2.87
Coherent $1.48 billion 4.08 $403.41 million $6.63 36.97

Coherent has higher revenue and earnings than Intermolecular. Intermolecular is trading at a lower price-to-earnings ratio than Coherent, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Intermolecular and Coherent’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Intermolecular -47.22% -43.57% -35.71%
Coherent 11.08% 24.98% 12.59%

Analyst Recommendations

This is a summary of current ratings for Intermolecular and Coherent, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intermolecular 0 1 0 0 2.00
Coherent 0 0 8 0 3.00

Coherent has a consensus target price of $296.13, suggesting a potential upside of 20.82%. Given Coherent’s stronger consensus rating and higher probable upside, analysts clearly believe Coherent is more favorable than Intermolecular.

Summary

Coherent beats Intermolecular on 11 of the 13 factors compared between the two stocks.

Intermolecular Company Profile

Intermolecular, Inc. provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems. It develops technology and Internet protocol (IP) rights focused on materials, processes, integration and device architectures in collaboration with its customers. Its HPC platform consists of tempus HPC processing, automated characterization and informatics and analysis software. The Company offers a series of wet processing tools and dry processing tools. Its informatics software includes workflow management software, analysis and reporting software, security and collaboration management software, and integration services. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies.

Coherent Company Profile

Coherent, Inc. is a photonics manufacturer. The Company is engaged in designing, manufacturing, servicing and marketing of lasers and related accessories for a range of scientific, commercial and industrial applications. It operates through two segments: Specialty Lasers and Systems (SLS) and Commercial Lasers and Components (CLC). SLS develops and manufactures configurable products serving the microelectronics, scientific research and government programs, and original equipment manufacturer (OEM) components and instrumentation markets. The Commercial Lasers and Components segment focuses on higher volume products that are offered in set configurations. The product architectures are designed for exchange at the point of use such that substantially all product service and repairs are based upon advanced replacement and depot (that is factory) repair. CLC’s primary markets include materials processing, OEM components, and instrumentation and microelectronics.

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Red Sox Waste Little Time in Firing John Farrell
Red Sox Waste Little Time in Firing John Farrell
Washington Nationals Sans Strasburg for Game 4 at Wrigley
Washington Nationals Sans Strasburg for Game 4 at Wrigley
Red Sox Beat Houston Sunday to Avoid Elimination
Red Sox Beat Houston Sunday to Avoid Elimination


Leave a Reply

 
© 2006-2017 BBNS.